Significance of macrolide resistance in Streptococcus pneumoniae

J Antimicrob Chemother. 2003 Sep;52(3):524-5; author reply 525. doi: 10.1093/jac/dkg349. Epub 2003 Jul 29.

Authors

Eric L Nuermberger, William R Bishai

PMID: 12888594
DOI: 10.1093/jac/dkg349

No abstract available

Publication types

Comment
Letter

MeSH terms

Aged
Amoxicillin-Potassium Clavulanate Combination / pharmacokinetics
Amoxicillin-Potassium Clavulanate Combination / therapeutic use
Anti-Bacterial Agents / pharmacology*
Bacteremia / drug therapy
Bacteremia / microbiology
Drug Resistance, Bacterial
Drug Therapy, Combination / pharmacokinetics
Drug Therapy, Combination / therapeutic use
Humans
Macrolides / pharmacology*
Methyltransferases / genetics
Pneumococcal Infections / drug therapy
Pneumococcal Infections / microbiology
Streptococcus pneumoniae / drug effects*
Streptococcus pneumoniae / genetics
Treatment Failure

Substances

Anti-Bacterial Agents
Macrolides
Amoxicillin-Potassium Clavulanate Combination
Methyltransferases
rRNA (adenosine-O-2'-)methyltransferase